Skip to content
The Policy VaultThe Policy Vault

dabigatran etexilate mesylate capsules — Medical Mutual

Deep Vein Thrombosis in a Patient Undergoing Knee Replacement Surgery, Prophylaxis

Initial criteria

  • Patient is age ≥ 18 years

Reauthorization criteria

  • Continuation requires response to therapy unless otherwise noted

Approval duration

60 days